Redesigning kidney trials for improved evidence and patient care
“If a drug improves creatinine but makes a patient too fatigued to work, that’s a safety signal we might be missing.” How can nephrology translate recent advances in research into better outcomes for people with kidney diseases? In the second episode of the ISN PARADIGM in Clinical Trials podcast series, drawing on insights from the Consensus Meeting on Changing Paradigms...
